Use of purinergic receptor agonists as antineoplastic agents

Details Use of purinergic receptor agonists as antineoplastic agents Use of purinergic receptor agonists as antineoplastic agents

1995-05-15

1997-06-24

Kishore, PhD, Gollamudi S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

514 47, 514 48, 514279, A61K 3170, A61K 908

Patent

active

056415001

ABSTRACT:
The instant invention is directed to the use of a pharmaceutical composition containing an effective amount of adenosine or an adenosine analog or derivative as an agent useful in the treatment of hormone-independent cancers, such as prostate cancer. The invention is also directed to diagnostic uses of these compounds to determine effective treatment regimes for specific tumors, a process for screening for new, therapeutically useful analogs of these compounds, and the use of these compounds in facilitating the extraction of intracellular components.

REFERENCES:
patent: 4690935 (1987-09-01), Taylor et al.
patent: 4950680 (1990-08-01), Taylor et al.
patent: 5415873 (1995-05-01), Trepel
Rapaport, Eur. J. Cancer. Clinical Oncology, 24, pp. 1491-1497, 1988.
Cusack, Biochem J., 214, pp. 975-981, 1983.
J.R. Fraumeni, Jr. et al, Principles and Practice of Oncology, 3rd Edition, 1989.
Kerr, et al, Virchows Arch. Abt. B. Zellpath, "Deletion of Cells by Apoptosis during Castration-Induced Involution of the Rat Prostate", 13:87-102, 1973.
Kyprianou et al, The Prostate, "Activation of a Ca.sup.2+ -Mg.sup.2+ -Dependent Endonuclease as an Early Event in Castration-Induced Prostatic Cell Death", 13:103-117 (1988).
Rapaport, Eur. Cancer Clin. Oncol., "Experimental Cancer Therapy in Mice By Adenine Nucleotides", 24:1491-7 (1988).
Smith et al, Nature, "Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures", vol. 337, pp. 181-184 (1989).
Trepel et al, Biochem. J., "Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small-cell lung-cancer cell line", 225:403-410 (1988).
Ucker, Nature, "Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells", vol. 327, pp. 62-64, 1987.
O'Connor et al, Trends in Pharmaceutical Sciences, "Extracellular ATP: effects, sources and fate", 12:137-141, 1991.
Gordon, Biochem. J., 223:309-319, 1986.
Webster's II New Riverside University Dictionary, p. 104, 1984.
Cusack et al, Biochem. J., "Steroselectivity of ectonucleotidases on vascular endothelial cells", 214:975-981, 1983.
Mason et al, Brit. J. Pharmacol., "Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium", 103:1649-1656, 1991.
Moody et al, Euro. J. Pharmacol., "Evidence for the presence of P.sub.1 -purinoceptors on cholinergic nerve terminals in the guinea-pig illeum", 77:1-9, 1982.
Jay S. Roth, "All About Cancer", published by George F. Stickley Company, p. 14, 1987.
Ogreid et al, Cancer Research, "Characterization of the Cyclic Adenosine 3':5'-Monophosphate Effector System in Hormone-dependent and Hormone-independent Rat Mammary Carcinomas", 47: 2576-2582, 1987.
Koschel, Eur. J. Biochem., "A Hormone-independent Rise of Adenosine 3',5'-Monophosphate Desensitized Coupling of .beta.-Adrenergic Receptors to Adenylate Cyclase in Rat Glioma C6-Cells", 108, 163-169, 1980.
Y.J. Bang et al, "Cyclic AMP Induces Transforming Growth Factor Beta-2 Gene Expression and Growth Arrest in the Human Androgen-Independent Prostate Carcinoma Cell Line PC-3"; Proc. Nat'l Acad. Sci., 89(8), pp. 3556-3560, 1992.
W.G. Fang et al, "P-2 Purinergic Receptor Agonsists Inhibit the Growth of Androgen-Independent Prostate Carcinoma Cells", J. Clin Invest, 89(1), pp. 191-196, 1992.
Y.J. Bang et al, "Mechanism of Negative Growth Control by Cyclic AMP in a Human Prostate Carcinoma Cell Line Cyclic AMP Induces Production Bioactive TGF-BETA-2 and Underphosphorylation of the Retinoblastoma Protein"; J. Cell Biochem. Suppl. 0 (16 Part B), p. 141, Abstract #G305, 1992.
Y.J. Bang et al, "Cyclic AMP Analogs Inhibit the Growth of Human Prostate Carcinoma Cells Evidence For The Role of Transforming Growth Factor-BETA-2; Proc. Am. Assoc. Cancer Res. Annual Meeting, " vol. 32, Abstract #326, 1991.
M.A. Oleshansky et al, "Exogenously-Added ATP Promotes Calcium-45 Influx in PC-3M Cells"; Soc. Neurosci. Abst. 16(2), p. 1173; Abstract #485.11; 1990.
Y. Sharoni et al, "Effect of Guanine and Adenine Nucleotides on Bombesin-Stimulated Phospholipase C Activity in Membranes From Swiss 3T3 and Small Cell Lung Carcinoma Cells"; Cancer Res. 50(17), pp. 5257-5262; 1990.
W.G. Fang et al, "Purinergic Receptor Agonists Stimulate Calcium Mobilization in Human Prostate Carcinoma Cell Lines"; J. Cell Biochem. Suppl., 0 (14 Part B); p. 257; Abstract #F111; 1990.
W.G. Fang et al, "Growth Inhibition of Androgen-Independent Prostate Carcinoma Cells Through Activation of Phospholipase C-Coupled Purinergic Receptors"; Proc. Am. Assoc. Cancer Res. Annual Meeting, 31(0), p. 226; Abstract #1343; 1990.

Affiliated with

Also associated with

Rating

Use of purinergic receptor agonists as antineoplastic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of purinergic receptor agonists as antineoplastic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of purinergic receptor agonists as antineoplastic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-147764